AHA 2024 Insights: Phase 2 Trial of Zerlasiran: Multiple Doses of an siRNA Targeting Lipoprotein(a) Over 60 Weeks

1,135 views
November 19, 2024
Comments 5
Login to view comments. Click here to Login